Cognitive factors for predicting treatment response in schizophrenic patients: One-year follow-up study

Psychiatry Investigation

Volumn 5, Issue 2, 2008, Pages 106-114

  Kim, Yong Ku ^a   Lee, Ae Ra ^a   Hur, Ji Won ^a   Yoon, Ho Kyung ^a   Lee, Bun Hee ^a   Ko, Young Hoon ^a  

^a Korea University   (South Korea)

Author keywords

Cognition; Predictor; Prognosis; Schizophrenia; Treatment response; Wisconsin card sorting test

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COGNITRONE TEST; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KOREAN MEMORY ASSESSMENT SCALE; LONGITUDINAL STUDY; MALE; PARANOID SCHIZOPHRENIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PROGNOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT RESPONSE; VERBAL MEMORY; VIGILANCE TEST; WISCONSIN CARD SORTING TEST;

EID: 46949091359     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2008.5.2.106     Document Type: Article

References (50)

1. Muller BW, Sartory G, Bender S. Neuropsychological Deficits and Concomitant Clinical Symptoms in Schizophrenia. European Psychologist 2004;9:96-106.
2. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler SH, Mayerhoff DI, Lieberman JA. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992;18:437-448.
3. Abrahamson D. Schizophrenic deterioration. 4. Br J Psychiatry 1983; 143:82-83.
4. Silverberg-Shalev R, Gordon HW, Bentin S, Aranson A. Selective language deterioration in chronic schizophrenia. J Neurol Neurosurg Psychiatry 1981;44:547-551.
5. Sweeney JA, Haas GL, Li S. Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia. Schizophr Bull 1992;18:283-293.
6. Sweeney JA, Haas GL, Keilp JG, Long M. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study. Psychiatry Res 1991;38:63-76.
7. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler S, Mayerhoff D, Lieberman JA. Neuropsychological deficits in the early course of first episode schizophrenia. Schizophr Res 1991;5:198-199.
8. Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992;149:898-903.
9. Nopoulos P, Flashman L, Flaum M, Arndt S, Andreasen N. Stability of cognitive functioning early in the course of schizophrenia. Schizophr Res 1994;14:29-37.
10. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-48.
11. Norman RM, Malla AK, Cortese L, Cheng S, Diaz K, Mcintosh E, et al. Symptoms and cognition as predictors of community functioning: a prospective analysis. Am J Psychiatry 1999;156:400-405.
12. Green M, Walker E. Neuropsychological performance and positive and negative symptoms in schizophrenia. J Abnorm Psychol 1985;94: 460-469.
13. Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987;17:49-57.
14. Censits DM, Ragland JD, Gur RC, Gur RE. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res 1997;24:289-298.
15. Hoff AL, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi LE. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am J Psychiatry 1999;156:1336-1341.
16. Lysaker PH, Bell MD, Bioty SM. Cognitive deficits in schizophrenia. Prediction of symptom change for participators in work rehabilitation. J Nerv Ment Dis 1995;183:332-336.
17. Smith RC, Largen J, Vroulis G, Ravichandran GK. Neuropsychological test scores and clinical response to neuroleptic drugs in schizophrenic patients. Compr Psychiatry 1992;33:139-145.
18. Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999;156: 544-549.
19. Chen EY, Hui CL, Dunn EL, Miao MY, Yeung WS, Wong CK, et al. A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients. Schizophr Res 2005;77: 99-104.
20. Green MR What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321-330.
21. Green MF, Kern RS, Braff DL Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 2000;26:119-136.
22. First M, Spitzer RL, Gibbon M, William JB. Structured clinical In- terview for DSM-IV Axis I Disorder- Patient Edition (SCID-I/P, version 2.0), Biometrics Research Department, New York State Psychiatric Institute, New York: American Psychiatric Press, Inc; 1998.
23. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
24. Lee C, Yoo HJ, Kim CY, Han OS Park IH. Korean standardization study of the vienna test system for clinical use (1): standard progressive matrices test of students in Seoul. J Korean Neuropsychiatr Assoc 1993; 32:252-258.
25. Schfried G. The PC/S Vienna test system: The Universal System for computer-aided diagnostics and therapy in psychology and medicine. Vienna: Schuhfried; 1988.
26. Lee HS, An, CI Jeong IK. A Preliminary Study on Standardization of K-MAS (Korean version of Memory Assessment Scales). Kor J Clin Psychol 1999;18:221-241.
27. Williams JM. Memory Assessment Scales. Odessa, FL: Psychological Assessment Resources; 1991.
28. Little MM, Williams JM, Long CJ. Clinical memory tests and everyday memory. Arch Clin Neuropsychol 1986;1:323-333.
29. Lezak MD. Neuropsychological assessment (ed.). New York: Oxford University Press; 1995.
30. Heaton RK. Wisconsin Card Sorting Test Manual: revised and expanded. Odessa, FL: Psychological Assessment Resources; 1993.
31. Stip E, Lussier I, Ngan E, Mendrek A, Liddle P. Discriminant cognitive factors in responder and non-responder patients with schizophrenia. Eur Psychiatry 1999;14:442-450.
32. Chaikelson JS, Schwartzman AE. Cognitive changes with aging in schizophrenia. J Clin Psychol 1983;39:25-30.
33. Russell AJ, Munro JC, Jones PB, Hemsley DR, Murray RM. Schizophrenia and the myth of intellectual decline. Am J Psychiatry 1997; 154:635-639.
34. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998; 155:1661-1670.
35. Stordal KI, Mykletun A, Asbjørnsen A, Egeland J, Landrø Nl, Roness A, et al. General psychopathology is more important for executive functioning than diagnosis. Acta Psychiatr Scand 2005;111:22-28.
36. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-246.
37. Capleton RA. Cognitive function in schizophrenia: association with negative and positive symptoms. Psychol Rep 1996;78:123-128.
38. Berman I, Viegner B, Merson A, Allan E, Pappas D, Green Al. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr Res 1997;25: 1-10.
39. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophr Bull 1999;25:173-182.
40. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophr Res 2000;44:47-56.
41. Lysaker P, Bell M, Beam-Goulet J. Wisconsin card sorting test and work performance in schizophrenia. Psychiatry Res 1995;56:45-51.
42. Lysaker PH, Bell MD, Zito WS, Bioty SM. Social skills at work. Deficits and predictors of improvement in schizophrenia. J Nerv Ment Dis 1995;183:688-692.
43. Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophr Res 2004;68:1-9.
44. Cirillo MA Seidman LJ. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev 2003;13:43-77.
45. Zihl J, Grön G, Brunnauer A. Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder. Acta Psychiatr Scand 1998;97:351-357.
46. Franke P, Maier W, Hain C Klingler T. Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia? Schizophr Res 1992;6: 243-249.
47. Bellack AS, Gold JM, Buchanan RW. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophr Bull 1999; 25:257-274.
48. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull 1999;25:309-319.
49. nd, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry 1990;47:615-621.
50. Cole JO, Goldberg SC, Davis JM. Drugs in the treatment of psychosis: controlled studies. Psychiatric drugs. Solomon P, editor. New York: Grune and Statton, 1966, p. 153-180.